메뉴 건너뛰기
Lancet
Volumn 362, Issue 9385, 2003, Pages 676-677
Simple deliverable therapy needed for childhood leukaemia
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT;
EID: 0042329270     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14241-9     Document Type: Note
Times cited : (20)
References (8)
  • 1
    • 78651010566 scopus 로고
    • Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)
    • Farber S., Diamond L., Mercer R., Sylvester R., Wolff J. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med. 238:1948;787-793.
    • (1948) N Engl J Med , vol.238 , pp. 787-793
    • Farber, S.1    Diamond, L.2    Mercer, R.3    Sylvester, R.4    Wolff, J.5
  • 2
    • 0037631926 scopus 로고    scopus 로고
    • Newly diagnosed childhood lymphoblastic leukemia: Update on prognostic factors and treatment
    • Silverman L.B., Sallan S.E. Newly diagnosed childhood lymphoblastic leukemia: update on prognostic factors and treatment. Curr Opin Hematol. 10:2003;290-296.
    • (2003) Curr Opin Hematol , vol.10 , pp. 290-296
    • Silverman, L.B.1    Sallan, S.E.2
  • 3
    • 0035124248 scopus 로고    scopus 로고
    • Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)
    • Hargrave D.R., Hann I.M., Richards S., et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII,X and XI). Br J Haematol. 112:2000;293-299.
    • (2000) Br J Haematol , vol.112 , pp. 293-299
    • Hargrave, D.R.1    Hann, I.M.2    Richards, S.3
  • 4
    • 0037006217 scopus 로고    scopus 로고
    • Science, medicine and the future: Childhood leukaemia
    • Greaves M. Science, medicine and the future: Childhood leukaemia. BMJ. 324:2002;283-287.
    • (2002) BMJ , vol.324 , pp. 283-287
    • Greaves, M.1
  • 5
    • 0038268132 scopus 로고    scopus 로고
    • Determination of minimal residual disease in leukaemia patients
    • Campana D. Determination of minimal residual disease in leukaemia patients. Br J Haematol. 121:2003;823-838.
    • (2003) Br J Haematol , vol.121 , pp. 823-838
    • Campana, D.1
  • 6
    • 0022625674 scopus 로고
    • Report to the Council by the Working Party on Childhood Leukaemia: Improvement in treatment for children with lymphoblastic leukaemia: The Medical Research Council UKALL Trials, 1972-1984
    • Report to the Council by the Working Party on Childhood Leukaemia: Improvement in treatment for children with lymphoblastic leukaemia:the Medical Research Council UKALL Trials, 1972-1984. Lancet 1986; 1: 408-11.
    • (1986) Lancet , vol.1 , pp. 408-411
  • 7
    • 0015240918 scopus 로고
    • Five year follow-up of "Total Therapy" of childhood lymphocytic leukemia
    • Pinkel D. Five year follow-up of "Total Therapy" of childhood lymphocytic leukemia. JAMA. 216:1971;648-652.
    • (1971) JAMA , vol.216 , pp. 648-652
    • Pinkel, D.1
  • 8
    • 0026500846 scopus 로고
    • Lessons from 20 years of curative therapy of childhood acute leukaemia
    • Pinkel D. Lessons from 20 years of curative therapy of childhood acute leukaemia. Br J Cancer. 65:1992;148-153.
    • (1992) Br J Cancer , vol.65 , pp. 148-153
    • Pinkel, D.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.